COLO-RECTAL CANCER (DMMR/MSI-H CRC)

Clinical trials for COLO-RECTAL CANCER (DMMR/MSI-H CRC) explained in plain language.

Never miss a new study

Get alerted when new COLO-RECTAL CANCER (DMMR/MSI-H CRC) trials appear

Sign up with your email to follow new studies for COLO-RECTAL CANCER (DMMR/MSI-H CRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Needle or drip? cancer patients choose their preferred immunotherapy method

Knowledge-focused Recruiting now

This study looks at whether people with certain cancers prefer getting their immunotherapy as a shot under the skin (subcutaneous) or through an IV drip. About 880 patients will try both methods and report which they like better. The goal is to understand patient preferences, not…

Matched conditions: COLO-RECTAL CANCER (DMMR/MSI-H CRC)

Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Knowledge-focused

Last updated May 01, 2026 16:00 UTC

COLO-RECTAL CANCER (DMMR/MSI-H CRC)

Get alerted when new COLO-RECTAL CANCER (DMMR/MSI-H CRC) trials appear

Needle or drip? cancer patients choose their preferred immunotherapy method